“I never imagined the online course would be so comprehensive, enjoyable, and easy to follow! ”

“After treatment, I was in a free fall. The Anticancer Lifestyle Program caught me and gave me the support I really needed.”

My breast cancer diagnosis was a wake up call. The Diet module helped me to learn the science behind the food rules I followed while raising my kids and has motivated me to get back to that healthier way of cooking and eating. Thank you!

View All Testimonials

BPA and methylparaben counteract tamoxifen and rapamycin, used to treat breast cancer

Environment
Articles & Research

A study by Goodson et al, published in the journal Carcinogenesis, found that treating breast cells with BPA led to marked resistance to rapamycin, which is used to treat breast cancer. Also, breast cells treated with either BPA or methylparaben (commonly used as a preservative in cosmetics and some medications) counteracted the beneficial anti-estrogenic effects of tamoxifen.

Overall, these xenoestrogens (a synthetic or natural hormone that imitates estrogen), when tested in benign breast cells from multiple human subjects, consistently initiated specific functional changes of the kind that are attributed to malignant onset in breast tissue.

The study concluded that their observations reinforce the concern that BPA and methylparaben, at low concentrations detected in humans, can have adverse health consequences.